HOME >> BIOLOGY >> NEWS
Gene therapy completely suppresses ovarian cancer growth in animal model

BALTIMORE University of Pittsburgh School of Medicine researchers have used gene therapy to either completely abolish or significantly inhibit tumor progression in a mouse model of ovarian cancer. The researchers believe these findings, which are being presented at the American Society of Gene Therapy annual meeting in Baltimore, May 31 to June 4, may significantly improve the prognosis for ovarian cancer patients.

Ovarian cancer is diagnosed in more than 25,000 women in the United States each year, and about 16,000 American women die from the disease annually. Despite aggressive surgery and chemotherapy approaches, the prognosis for ovarian cancer is poor, and most women have a life expectancy of only three to four years after their diagnoses.

In this study, the Pitt investigators inoculated mice with an ovarian cancer cell line. They treated some of the mice immediately with a genetically engineered vaccinia virus containing a gene coding cytosine deaminase, a suicide gene, and delayed treatment of other mice for 30 or 60 days. Control mice were inoculated with ovarian cancer cells but were not given the gene therapy.

The researchers found complete inhibition of tumor growth in the mice that were treated immediately with gene therapy and significant tumor inhibition in the 30- and 60-day delayed treatment mice. In contrast, all non-gene-therapy treated mice either died or were euthanized due to overwhelming buildup of fluid in the peritoneal cavity by 94 days following tumor inoculation.

According to corresponding author David L. Bartlett, M.D., professor of surgery and chief of the division of surgical oncology at the University of Pittsburgh School of Medicine, gene therapy offers an attractive new approach for treating ovarian cancer. "Current treatments for ovarian cancer are fairly harsh. Given their tumor selectivity and cancer killing potential, vaccinia vectors expressing recombinant gene products represents a potent, non
'"/>


3-Jun-2006


Page: 1 2

Related biology news :

1. Testosterone replacement therapy: How safe for aging men?
2. Progesterone therapy and preterm birth: More evidence helps identify women who can benefit
3. Aggressive therapy best for certain AML patients
4. Under magnetic force, nanoparticles may deliver gene therapy
5. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
6. Stem cell therapy rescues motor neurons in ALS model
7. Study identifies new gene therapy tools for inherited blindness
8. Breast cancer and hormone therapy -- A looking-glass mirror?
9. Radiation therapy combined with microsurgery shows promise for curing injured spinal cord
10. Nodal status is best predictor of outcome after neoadjuvant therapy for esophageal cancer
11. Scientists follow familiar TRAIL to new cancer therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/20/2020)... ... March 20, 2020 , ... ImStem Biotechnology, Inc. (Farmington CT), ... mesenchymal stem cells (hES-MSC), through a proprietary method using a trophoblast intermediate stage ... orphan diseases, today announced that the U.S. Food and Drug Administration (FDA) has ...
(Date:3/13/2020)... ... March 13, 2020 , ... Cryo-Cell ... stored cord blood performed by Dr. Hal Boxmeyer and colleagues, which determined sample ... cryogenically preserved cells under proper conditions. Cryo-Cell International marks the first family cord ...
(Date:3/11/2020)... ... March 11, 2020 , ... USARAD Holdings Inc., the ... and several healthcare VC firms introduces a first of its kind COVID-19 screening ... and has caused over 4,000 fatalities to date. Over the years, USARAD through ...
Breaking Biology News(10 mins):
(Date:3/3/2020)... (PRWEB) , ... March 03, 2020 , ... ... was invited to present the latest breast implant technology at the IMCAS Innovation ... and new innovations in the dermatology, plastic surgery, and aesthetic science industries that ...
(Date:2/28/2020)... SAN DIEGO (PRWEB) , ... February 26, 2020 ... ... HS7 system combines a high-speed camera with a dedicated controller, thus ... 2500 frames per second, the HS7 is the first of Fastec Imaging’s new ...
(Date:2/21/2020)... (PRWEB) , ... February 20, 2020 , ... In a ... join guest speakers from Synteract including Lisa Dilworth, BS, MS, Vice President ... about these challenges, with feasible strategies and solutions to support patients, sites and sponsors. ...
(Date:2/21/2020)... ... February 20, 2020 , ... The dietary supplement industry ... that what’s listed on an ingredient panel is actually in their product. ... with the adoption of CertainT, which is designed to protect the intellectual property ...
Breaking Biology Technology:
Cached News: